Effect of Plasmodium falciparum sulfadoxinepyrimethamine resistance on the

  • Slides: 5
Download presentation
Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for

Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis Anna Maria van Eijk, Ph. D, David A Larsen, Ph. D, Kassoum Kayentao, Ph. D, Gibby Koshy, Ph. D, Douglas E C Slaughter, SB, Cally Roper, Ph. D, Lucy C Okell, Ph. D, Meghna Desai, Ph. D, Julie Gutman, MD, Carole Khairallah, MSc, Prof Stephen J Rogerson, Ph. D, Prof Carol Hopkins Sibley, Ph. D, Prof Steven R Meshnick, MD, Steve M Taylor, MD, Prof Feiko O ter Kuile, Ph. D The Lancet Infectious Diseases Volume 19 Issue 5 Pages 546 -556 (May 2019) DOI: 10. 1016/S 1473 -3099(18)30732 -1 Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4. 0 license Terms and Conditions

Figure 1 The Lancet Infectious Diseases 2019 19546 -556 DOI: (10. 1016/S 1473 -3099(18)30732

Figure 1 The Lancet Infectious Diseases 2019 19546 -556 DOI: (10. 1016/S 1473 -3099(18)30732 -1) Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4. 0 license Terms and Conditions

Figure 2 The Lancet Infectious Diseases 2019 19546 -556 DOI: (10. 1016/S 1473 -3099(18)30732

Figure 2 The Lancet Infectious Diseases 2019 19546 -556 DOI: (10. 1016/S 1473 -3099(18)30732 -1) Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4. 0 license Terms and Conditions

Figure 3 The Lancet Infectious Diseases 2019 19546 -556 DOI: (10. 1016/S 1473 -3099(18)30732

Figure 3 The Lancet Infectious Diseases 2019 19546 -556 DOI: (10. 1016/S 1473 -3099(18)30732 -1) Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4. 0 license Terms and Conditions

Figure 4 The Lancet Infectious Diseases 2019 19546 -556 DOI: (10. 1016/S 1473 -3099(18)30732

Figure 4 The Lancet Infectious Diseases 2019 19546 -556 DOI: (10. 1016/S 1473 -3099(18)30732 -1) Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4. 0 license Terms and Conditions